• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外源性糖皮质激素对与战斗相关的创伤后应激障碍症状的影响。

Effects of exogenous glucocorticoid on combat-related PTSD symptoms.

作者信息

Surís Alina, North Carol, Adinoff Bryon, Powell Craig M, Greene Robert

机构信息

VA North Texas Health Care System, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75216, USA.

出版信息

Ann Clin Psychiatry. 2010 Nov;22(4):274-9.

PMID:21180658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3917156/
Abstract

BACKGROUND

Very few systematic human studies focus on changing the underlying traumatic memory after posttraumatic stress disorder (PTSD) has been established. Evidence from animal and human studies indicates that cortisol can be used to address traumatic memories. This translational pilot study is based on our previous rodent research in which extinction of fear memories was enhanced by glucocorticoids. The current study aims to assess the effectiveness of glucocorticoids in augmenting memory extinction and reducing clinical symptoms in veterans with combat-related PTSD.

METHODS

In a double-blind, placebo-controlled study, veterans with combat-related PTSD were exposed to a memory reactivation task using well established imagery and psychophysiology assessment technique followed by administration of either glucocorticoid or placebo.

RESULTS

One week after glucocorticoid or placebo administration, participants who received the study medication showed significant PTSD-related symptom (cluster C) improvement compared with control participants who received placebo only. However, reduction of symptoms degraded at a 1-month postadministration assessment.

CONCLUSIONS

These findings are consistent with a glucocorticoid-mediated enhancement of extinction to ameliorate PTSD symptoms. The use of traumatic memory reactivation temporally paired with glucocorticoid administration holds potential for developing a viable therapeutic option.

摘要

背景

很少有系统的人体研究聚焦于创伤后应激障碍(PTSD)确立后改变潜在的创伤性记忆。动物和人体研究的证据表明,皮质醇可用于处理创伤性记忆。这项转化性初步研究基于我们之前对啮齿动物的研究,在该研究中糖皮质激素增强了恐惧记忆的消退。当前研究旨在评估糖皮质激素增强退伍军人与战斗相关的创伤后应激障碍记忆消退及减轻临床症状的有效性。

方法

在一项双盲、安慰剂对照研究中,与战斗相关的创伤后应激障碍退伍军人通过成熟的意象和心理生理学评估技术接触记忆再激活任务,随后给予糖皮质激素或安慰剂。

结果

在给予糖皮质激素或安慰剂一周后,接受研究药物的参与者与仅接受安慰剂的对照参与者相比,创伤后应激障碍相关症状(C类)有显著改善。然而,在给药后1个月的评估中症状减轻情况有所恶化。

结论

这些发现与糖皮质激素介导的消退增强以改善创伤后应激障碍症状一致。将创伤性记忆再激活与糖皮质激素给药在时间上配对使用,具有开发可行治疗方案的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda1/3917156/24e8cb24b667/nihms341152f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda1/3917156/24e8cb24b667/nihms341152f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda1/3917156/24e8cb24b667/nihms341152f1.jpg

相似文献

1
Effects of exogenous glucocorticoid on combat-related PTSD symptoms.外源性糖皮质激素对与战斗相关的创伤后应激障碍症状的影响。
Ann Clin Psychiatry. 2010 Nov;22(4):274-9.
2
Facilitating Fear-Based Memory Extinction With Dexamethasone: A Randomized Controlled Trial in Male Veterans With Combat-Related PTSD.用地塞米松促进基于恐惧的记忆消退:一项针对患有与战斗相关创伤后应激障碍的男性退伍军人的随机对照试验。
Psychiatry. 2017 Winter;80(4):399-410. doi: 10.1080/00332747.2017.1286892.
3
Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome.皮质醇增强心理治疗对患有创伤后应激障碍的战士的疗效:随机试验表明治疗依从性和治疗效果得到改善。
Psychoneuroendocrinology. 2015 Jan;51:589-97. doi: 10.1016/j.psyneuen.2014.08.004. Epub 2014 Aug 13.
4
Pharmacological blockade of memory reconsolidation in posttraumatic stress disorder: three negative psychophysiological studies.创伤后应激障碍中记忆再巩固的药理学阻断:三项阴性心理生理学研究。
Psychiatry Res. 2015 Jan 30;225(1-2):31-39. doi: 10.1016/j.psychres.2014.09.005. Epub 2014 Sep 16.
5
Interfering with the reconsolidation of traumatic memory: sirolimus as a novel agent for treating veterans with posttraumatic stress disorder.干扰创伤性记忆的重新巩固:西罗莫司作为治疗创伤后应激障碍退伍军人的新型药物。
Ann Clin Psychiatry. 2013 Feb;25(1):33-40.
6
Glucocorticoid-induced reduction of traumatic memories: implications for the treatment of PTSD.糖皮质激素诱导的创伤性记忆减退:对创伤后应激障碍治疗的启示
Prog Brain Res. 2008;167:239-47. doi: 10.1016/S0079-6123(07)67017-4.
7
Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects.静脉注射氢化可的松对创伤后应激障碍患者及健康对照者的认知影响。
Ann N Y Acad Sci. 2006 Jul;1071:410-21. doi: 10.1196/annals.1364.032.
8
A randomized, double-blind, placebo-controlled trial of hydrocortisone augmentation of Prolonged Exposure for PTSD in U.S. combat veterans.一项针对美国参战退伍军人创伤后应激障碍的延长暴露治疗中氢化可的松增效作用的随机、双盲、安慰剂对照试验。
Behav Res Ther. 2021 Sep;144:103924. doi: 10.1016/j.brat.2021.103924. Epub 2021 Jul 1.
9
Glucocorticoids for the treatment of post-traumatic stress disorder and phobias: a novel therapeutic approach.糖皮质激素用于治疗创伤后应激障碍和恐惧症:一种新的治疗方法。
Eur J Pharmacol. 2008 Apr 7;583(2-3):365-71. doi: 10.1016/j.ejphar.2007.11.068. Epub 2008 Jan 24.
10
A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans.D-环丝氨酸或阿普唑仑联合虚拟现实暴露疗法治疗伊拉克和阿富汗战争退伍军人创伤后应激障碍的随机双盲评估。
Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625.

引用本文的文献

1
Exogenous glucocorticoids to improve extinction learning for post-traumatic stress disorder patients with hypothalamic-pituitary-adrenal-axis dysregulation: a study protocol description.外源性糖皮质激素改善下丘脑-垂体-肾上腺轴失调的创伤后应激障碍患者的消退学习:研究方案描述。
Eur J Psychotraumatol. 2024;15(1):2364441. doi: 10.1080/20008066.2024.2364441. Epub 2024 Jul 8.
2
Corticosterone after early adolescent stress prevents social avoidance, aversive behavior, and morphine-conditioned place preference in adulthood.青春期早期应激后皮质酮可预防成年期的社交回避、厌恶行为和吗啡条件性位置偏爱。
Psychopharmacology (Berl). 2024 Oct;241(10):2045-2059. doi: 10.1007/s00213-024-06616-7. Epub 2024 May 28.
3

本文引用的文献

1
Pharmacological manipulation of memory reconsolidation: towards a novel treatment of pathogenic memories.记忆再巩固的药理学调控:迈向对病理性记忆的新型治疗
Eur J Pharmacol. 2008 May 13;585(2-3):453-7. doi: 10.1016/j.ejphar.2008.03.010. Epub 2008 Mar 18.
2
Glucocorticoid-induced reduction of traumatic memories: implications for the treatment of PTSD.糖皮质激素诱导的创伤性记忆减退:对创伤后应激障碍治疗的启示
Prog Brain Res. 2008;167:239-47. doi: 10.1016/S0079-6123(07)67017-4.
3
Administration of corticosterone after memory reactivation disrupts subsequent retrieval of a contextual conditioned fear memory: dependence upon training intensity.
Neuroendocrine and cellular mechanisms in stress resilience: From hormonal influence in the CNS to mitochondrial dysfunction and oxidative stress.
应激适应的神经内分泌和细胞机制:从中枢神经系统的激素影响到线粒体功能障碍和氧化应激。
J Cell Mol Med. 2024 Apr;28(7):e18220. doi: 10.1111/jcmm.18220.
4
Innate and adaptive immune system consequences of post-traumatic stress disorder.创伤后应激障碍对固有和适应性免疫系统的影响。
Auton Neurosci. 2024 Apr;252:103159. doi: 10.1016/j.autneu.2024.103159. Epub 2024 Feb 23.
5
Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review.创伤后应激障碍的治疗:最新综述。
Curr Neuropharmacol. 2024;22(4):557-635. doi: 10.2174/1570159X21666230428091433.
6
The influence of sleep on fear extinction in trauma-related disorders.睡眠对创伤相关障碍中恐惧消退的影响。
Neurobiol Stress. 2022 Nov 7;22:100500. doi: 10.1016/j.ynstr.2022.100500. eCollection 2023 Jan.
7
Appraising reconsolidation theory and its empirical validation.评估再巩固理论及其实证验证。
Psychon Bull Rev. 2023 Apr;30(2):450-463. doi: 10.3758/s13423-022-02173-2. Epub 2022 Sep 9.
8
The role of the immune system in posttraumatic stress disorder.免疫系统在创伤后应激障碍中的作用。
Transl Psychiatry. 2022 Aug 4;12(1):313. doi: 10.1038/s41398-022-02094-7.
9
Neuroinflammation in Post-Traumatic Stress Disorder.创伤后应激障碍中的神经炎症
Biomedicines. 2022 Apr 20;10(5):953. doi: 10.3390/biomedicines10050953.
10
Randomized controlled experimental study of hydrocortisone and D-cycloserine effects on fear extinction in PTSD.随机对照实验研究地塞米松和 D-环丝氨酸对 PTSD 中恐惧消退的影响。
Neuropsychopharmacology. 2022 Oct;47(11):1945-1952. doi: 10.1038/s41386-021-01222-z. Epub 2021 Nov 19.
记忆重新激活后给予皮质酮会干扰随后情境性条件恐惧记忆的提取:依赖于训练强度。
Neurobiol Learn Mem. 2008 Feb;89(2):178-84. doi: 10.1016/j.nlm.2007.07.005. Epub 2007 Aug 16.
4
Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial.女性创伤后应激障碍的认知行为疗法:一项随机对照试验。
JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820.
5
Postreactivation glucocorticoids impair recall of established fear memory.再激活后使用糖皮质激素会损害已建立的恐惧记忆的回忆。
J Neurosci. 2006 Sep 13;26(37):9560-6. doi: 10.1523/JNEUROSCI.2397-06.2006.
6
Psychosocial therapy for posttraumatic stress disorder.创伤后应激障碍的心理社会治疗
J Clin Psychiatry. 2006;67 Suppl 2:40-5.
7
Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics.伴有和不伴有认知重构的创伤后应激障碍延长暴露随机试验:学术诊所和社区诊所的结果
J Consult Clin Psychol. 2005 Oct;73(5):953-64. doi: 10.1037/0022-006X.73.5.953.
8
Systemic and intra-amygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear.全身性及杏仁核内给予糖皮质激素激动剂和拮抗剂可调节条件性恐惧的消退。
Neuropsychopharmacology. 2006 May;31(5):912-24. doi: 10.1038/sj.npp.1300899.
9
The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.16项抑郁症状快速检查表(QIDS)、临床医生评定版(QIDS-C)和自我报告版(QIDS-SR):对慢性重度抑郁症患者的心理测量学评估
Biol Psychiatry. 2003 Sep 1;54(5):573-83. doi: 10.1016/s0006-3223(02)01866-8.
10
Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder.单独使用想象暴露疗法以及结合认知重构的想象暴露疗法治疗创伤后应激障碍
J Consult Clin Psychol. 2003 Aug;71(4):706-12. doi: 10.1037/0022-006x.71.4.706.